A Second Tour of Duty… Lessons Learned with Annalisa Jenkins
Annalisa Jenkins, new CEO of PlaqueTec, began her first tour of duty with the British Navy as a medical officer, but has since climbed the ranks of pharma to become a CEO and member of numerous boards.
Annalisa Jenkins |
The battlefield and the boardroom are more similar than you might think
For me, everything started with the military. I was raised in a military family and when I was searching for financial support for my medical studies it seemed a good time to join the British Navy, which had just started to open its doors to women in the medical branch. I served as a medical officer in the British Navy and was part of the Minesweeper Squadron during the Gulf conflict. Ultimately, I rose to the rank of Surgeon Lieutenant Commander, but after my tour of duty I wanted to go back into research, so I trained in cardiovascular medicine. I worked for the National Heart and Lung Institute, where I investigated the role of cholesterol on atheromatous plaques, and in 1997 I was offered the opportunity to join the pharma industry as a cardiovascular medical advisor at Bristol-Myers Squib (BMS), which was an exciting opportunity; in the 1990s, BMS was one of the top cardiovascular companies in the world.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine